{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:47:47Z","timestamp":1789015667555,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Danish Diabetes Academy"},{"DOI":"10.13039\/100007460","name":"Arvid Nilssons Fond","doi-asserted-by":"publisher","award":["6000603"],"award-info":[{"award-number":["6000603"]}],"id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.mcn.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T02:54:06Z","timestamp":1514429646000},"page":"118-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington's disease model"],"prefix":"10.1016","volume":"88","author":[{"given":"Regina Hertfelder","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Hvidberg","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie Wennemoes","family":"Willert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynne","family":"Nymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Dall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas T.","family":"Treebak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Silahtaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis","family":"Hasholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"N\u00f8rrem\u00f8lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2017.12.009_bb0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.chembiol.2006.05.012","article-title":"Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cells","volume":"13","author":"Altmann","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0015","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcn.2017.12.009_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2017.12.009_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1261\/rna.783108","article-title":"MicroRNA expression in the adult mouse central nervous system MicroRNA expression in the adult mouse central nervous system","volume":"14","author":"Bak","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.mcn.2017.12.009_bb0030","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes","volume":"17","author":"Bommer","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2017.12.009_bb0045","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0050","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/hmg\/dds178","article-title":"Transducer of regulated creb-binding proteins (TORCs) transcription and function is impaired in Huntington's disease","volume":"21","author":"Chaturvedi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0055","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1073\/pnas.1934713100","article-title":"Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice","volume":"100","author":"Cheng","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2017.12.009_bb0060","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.mcn.2017.12.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002797","article-title":"Intact p53-dependent responses in miR-34-deficient mice","volume":"8","author":"Concepcion","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0070","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/emboj.2012.65","article-title":"Shaping the role of mitochondria in the pathogenesis of Huntington's disease","volume":"31","author":"Costa","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2017.12.009_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2017.12.009_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2017.12.009_bb0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/jn.00762.2011","article-title":"A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington's disease","volume":"107","author":"Cummings","year":"2012","journal-title":"J. Neurophysiol."},{"issue":"277","key":"10.1016\/j.mcn.2017.12.009_bb0090","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal Intranuclear inclusions and dystrophic neurites in brain","volume":"80","author":"Difiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mcn.2017.12.009_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40263-013-0055-0","article-title":"Targeting Sirtuin-1 in Huntington's disease: rationale and current status","volume":"27","author":"Duan","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mcn.2017.12.009_bb0100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/ddt458","article-title":"P53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin","volume":"23","author":"Ehrnhoefer","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0105","doi-asserted-by":"crossref","first-page":"E8352","DOI":"10.1073\/pnas.1706945114","article-title":"Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1","volume":"114","author":"Fang","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mcn.2017.12.009_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1209021","article-title":"P53 tumor suppressor protein regulates the levels of huntingtin gene expression","volume":"25","author":"Feng","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.mcn.2017.12.009_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-60761-629-0_4","article-title":"Quantitative RT-PCR methods for mature microRNA expression analysis","volume":"630","author":"Fiedler","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"FEB","key":"10.1016\/j.mcn.2017.12.009_bb0120","first-page":"1","article-title":"Regulation of sirtuin function by posttranslational modifications","volume":"3","author":"Flick","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0125","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1\u03b1 and BDNF gene expression in a mouse model of Huntington's disease","volume":"41","author":"Hathorn","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the MicroRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mcn.2017.12.009_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuron.2014.01.028","article-title":"SIRT1 in neurodevelopment and brain senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2017.12.009_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mcn.2017.12.009_bb0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2009-0026","article-title":"The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways","volume":"31","author":"Houtkooper","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mcn.2017.12.009_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0175","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","article-title":"Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells","volume":"74","author":"Hwang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mcn.2017.12.009_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","article-title":"Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway","volume":"18","author":"Jeong","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcn.2017.12.009_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1\u03b1, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2017.12.009_bb0190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.nbd.2010.08.009","article-title":"Reduced gluconeogenesis and lactate clearance in Huntington's disease","volume":"40","author":"Josefsen","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0006611","article-title":"CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage","volume":"4","author":"Kang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2017.12.009_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","article-title":"Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study","volume":"48","author":"Kong","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0205","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington's disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0215","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1194\/jlr.M800509-JLR200","article-title":"Differential expression of microRNAs in mouse liver under aberrant energy metabolic status","volume":"50","author":"Li","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mcn.2017.12.009_bb0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2017.12.009_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2014.07.008","article-title":"Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice","volume":"71","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0230","article-title":"Regulation of neuronal cell cycle and apoptosis by miR-34a","volume":"36","author":"Modi","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0240","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.bbadis.2015.07.003","article-title":"Sirtuins: double players in Huntington's disease","volume":"1852","author":"Naia","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0245","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","article-title":"Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington's disease models","volume":"54","author":"Naia","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2015.00064","article-title":"SIRT1 in the brain\u2014connections with aging-associated disorders and lifespan","volume":"9","author":"Ng","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.mcn.2017.12.009_bb0255","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2008.04.065","article-title":"Modulation of SIRT1 expression in different neurodegenerative models and human pathologies","volume":"154","author":"Pall\u00e0s","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2017.12.009_bb0260","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijdevneu.2008.07.016","article-title":"Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid","volume":"26","author":"Pelegr\u00ed","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.mcn.2017.12.009_bb0265","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2017"},{"key":"10.1016\/j.mcn.2017.12.009_bb0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/cancers7010030","article-title":"P53 acetylation: regulation and consequences","volume":"7","author":"Reed","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcn.2017.12.009_bb0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2017.12.009_bb0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jmcb\/mju003","article-title":"The p53\/miR-34 axis in development and disease","volume":"6","author":"Rokavec","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2009.04.034","article-title":"Detection of early behavioral markers of Huntington's disease in R6\/2 mice employing an automated social home cage","volume":"203","author":"Rudenko","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mcn.2017.12.009_bb0290","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nbd.2006.08.002","article-title":"Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis","volume":"24","author":"Ryan","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0295","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","article-title":"Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington's disease","volume":"12","author":"Samadi","year":"2013","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.mcn.2017.12.009_bb0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","article-title":"Huntington's disease: the current state of research with peripheral tissues","volume":"219","author":"Sassone","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0305","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0310","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","article-title":"Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2017.12.009_bb0315","first-page":"95","article-title":"Fluorescence in situ hybridization for detection of small RNAs on frozen tissue sections, in","author":"Silahtaroglu","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mcn.2017.12.009_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/srep12166","article-title":"Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression","volume":"5","author":"Southwell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2017.12.009_bb0325","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2011.02.008","article-title":"Gene expression profiling of R6\/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease","volume":"42","author":"Tang","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2017.12.009_bb0330","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2017.12.009_bb0335","article-title":"Correction: SIRT1 activity is linked to its brain region-specific phosphorylation and is impaired in Huntington's disease mice","volume":"11","author":"Tulino","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2017.12.009_bb0340","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0345","article-title":"Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2017.12.009_bb0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.dnarep.2017.02.001","article-title":"The NAD(+) precursor nicotinic acid improves genomic integrity in human peripheral blood mononuclear cells after X-irradiation","volume":"52","author":"Weidele","year":"2017","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.mcn.2017.12.009_bb0355","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1\u03b1 in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.mcn.2017.12.009_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4a16d713-6dd6-4366-96a8-71d316456f98","article-title":"Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease","volume":"5","author":"Wood","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2017.12.009_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2012.00068","article-title":"MicroRNA regulation of SIRT1","volume":"3","author":"Yamakuchi","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mcn.2017.12.009_bb0370","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for Huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mcn.2017.12.009_bb0375","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2012.01.015","article-title":"An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease","volume":"229","author":"Zarringhalam","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mcn.2017.12.009_bb0380","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.neuroimage.2009.10.027","article-title":"Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images","volume":"49","author":"Zhang","year":"2010","journal-title":"NeuroImage"}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743117300994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743117300994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:07:17Z","timestamp":1760922437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743117300994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":76,"alternative-id":["S1044743117300994"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2017.12.009","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington's disease model","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}